Supplementation of exogenous ghrelin, which is significantly reduced in HFD-induced obesity, may restore the oscillation of hepatic clock genes and the dysfunction of lipid metabolism in the liver. Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.